majority of participants in the prescription medicines and vaccines market are body corporates. Options 2 and 3 are more aligned to Canada’s enforcement approach which takes a graduated, risk-based approach, in which available regulatory measures range from public warnings or advisories to investigation and referral for prosecution of an offence, with applicable fines and penalties. The UK is also proposing significant financial penalties for non-reporting of medicine shortages. For consideration PROPOSED COMPLIANCE: Three options are presented in the table above. SOME QUESTIONS TO CONSIDER: Do you support particular options? Why? Which option, or combination of options, do you believe would be the most effective?
majority of participants in the prescription medicines and vaccines market are body corporates. Options 2 and 3 are more aligned to Canada’s enforcement approach which takes a graduated, risk-based approach, in which available regulatory measures range from public warnings or advisories to investigation and referral for prosecution of an offence, with applicable fines and penalties. The UK is also proposing significant financial penalties for non-reporting of medicine shortages. For consideration PROPOSED COMPLIANCE: Three options are presented in the table above. SOME QUESTIONS TO CONSIDER: Do you support particular options? Why? Which option, or combination of options, do you believe would be the most effective?
consultation-management-and-communication-of-medicines-shortages.docx